摘要
目的探讨卡维地洛联合螺内酯治疗原发性高血压临床效果。方法 480例原发性高血压患者,随机分为观察组和对照组,各240例。对照组给予卡维地洛,观察组给予卡维地洛和螺内酯,观察两组患者血压治疗效果。结果两组治疗后收缩压、舒张压分别和本组治疗前比较,差异有统计学意义(P<0.05);治疗后观察组收缩压、舒张压与对照组比较,差异有统计学意义(P<0.05)。观察组治疗总有效率高于对照组(P<0.05)。结论卡维地洛联合螺内酯治疗原发性高血压疗效显著,值得借鉴。
Objective To investigate clinical effect by carvedilol combined with spirolactone in the treatment of hypertension. Methods A total of 480 primary hypertension patients were randomly divided into observation group and control group, with 240 cases in each group. The control group received carvedilol, and the observation group received carvedilol combined with spirolactone. Curative effects on blood pressure were observed in both groups. Results Comparing with those before treatment, both groups had statistical significant differences of systolic pressure and diastolic pressure after treatment（P〈0.05）. The difference of systolic pressure and diastolic pressure after treatment had statistical significance between the observation group and the control group（P〈0.05）. The observation group had higher total effective rate than the control group（P〈0.05）. Conclusion Combination of carvedilol and spirolactone provides precisely curative effect for primary hypertension, and it is worth referring.
出处
《中国实用医药》
2016年第18期41-42,共2页
China Practical Medicine
关键词
原发性高血压
卡维地洛
螺内酯
临床效果
Primary hypertension
Carvedilol
Spirolactone
Clinical effect
